发明名称 |
Insulin-like growth factor mimetics for use in therapy |
摘要 |
This relates to the use of an IGF-1 mimetic in human therapy. In particular, disclosed herein is the use of an IGF-1 precursor protein, particularly a human IGF-1 precursor protein, comprising the E-peptide for the treatment of Spinal and Bulbar Muscular Atrophy (SBMA) in a patient suffering from said disease. |
申请公布号 |
AU2014330853(A1) |
申请公布日期 |
2016.02.25 |
申请号 |
AU20140330853 |
申请日期 |
2014.09.30 |
申请人 |
NOVARTIS AG;NATIONAL INSTITUTES OF HEALTH |
发明人 |
FISCHBECK, KENNETH;GLASS, DAVID |
分类号 |
A61K38/30;A61P21/00 |
主分类号 |
A61K38/30 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|